Necdin: A multi functional protein with potential tumor suppressor role?

Molecular Carcinogenesis

Volumn 48, Issue 11, 2009, Pages 975-981

  Chapman, Emma J ^a   Knowles, Margaret A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Candidate tumor suppressor gene; NDN; Working hypothesis

Indexed keywords

BMI1 PROTEIN; NECDIN; NEUROTROPHIN RECEPTOR P75; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

CANCER INHIBITION; CELL DIFFERENTIATION; GENE INTERACTION; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; PATIENT MONITORING; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

CELL DIFFERENTIATION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 15; GENES, TUMOR SUPPRESSOR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PRADER-WILLI SYNDROME; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70350442650     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20567     Document Type: Review

References (44)

1. Maruyama K, Usami M, Aizawa T, Yoshikawa K. A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryonal carcinoma cells. Biochem Biophys Res Commun 1991;178:291-296.
2. Barker PA, Salehi A. The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 2002;67:705-712. (Pubitemid 34226281)
3. Xiao J, Chen HS. Biological functions of melanoma-associated antigens. World J Gastroenterol 2004;10:1849-1853.
4. Kuwajima T, Nishimura I, Yoshikawa K. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J Neurosci 2006;26:5383-5392. (Pubitemid 44318390)
5. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003;5:474-479. (Pubitemid 36592272)
6. Bollmann FM. The many faces of telomerase: Emerging extratelomeric effects. Bioessays 2008;30:728-732.
7. Chapman EJ, Kelly G, Knowles MA. Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol Cancer Res 2008;6:1154-1168.
8. Chapman EJ, Hurst CD, Pitt E, Chambers P, Aveyard JS, Knowles MA. Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway. Oncogene 2006;25:5037-5045. (Pubitemid 44246362)
9. Jay P, Rougeulle C, Massacrier A, et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet 1997;17:357-361. (Pubitemid 27476006)
10. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: Implications for human disease.AmJ Pathol 1999;154:635-647.
11. Li Y, Meng G, Guo QN. Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma. Exp Mol Pathol 2008;84:234-239.
12. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007;9:166-180. (Pubitemid 46318375)
13. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006;24:778-789. (Pubitemid 46622045)
14. Talantov D, Mazumder A, Yu JX, et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005;11:7234-7242. (Pubitemid 41507680)
15. Taniura H, Taniguchi N, Hara M, Yoshikawa K. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J Biol Chem 1998;273:720-728. (Pubitemid 28049158)
16. Ohman Forslund K, Nordqvist K. The melanoma antigen genes - Any clues to their functions in normal tissues? Exp Cell Res 2001;265:185-194.
17. Kuwako K, Taniura H, Yoshikawa K. Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor. J Biol Chem 2004;279:1703-1712. (Pubitemid 38084437)
18. Bush JR, Wevrick R. The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation. Differentiation 2008;76:994-1005.
19. Taniura H, Matsumoto K, Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem 1999;274:16242- 16248. (Pubitemid 129526374)
20. Hasegawa K, Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci 2008;28:8772-8784.
21. Liu Y, Elf SE, Miyata Y, et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009;4:37-48.
22. Matsumoto K, Taniura H, Uetsuki T, Yoshikawa K. Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters. Gene 2001;272:173-179. (Pubitemid 32695410)
23. Friedman ER, Fan CM. Separate necdin domains bind ARNT2 and HIF1alpha and repress transcription. Biochem Biophys Res Commun 2007;363:113-118.
24. Moon HE, Ahn MY, Park JA, Min KJ, Kwon YW, Kim KW. Negative regulation of hypoxia inducible factor-1alpha by necdin. FEBS Lett 2005;579:3797-3801.
25. Takazaki R, Nishimura I, Yoshikawa K. Necdin is required for terminal differentiation and survival of primary dorsal root ganglion neurons. Exp Cell Res 2002;277:220-232. (Pubitemid 34757103)
26. Kurita M, Kuwajima T, Nishimura I, Yoshikawa K. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis. J Neurosci 2006;26:12003-12013. (Pubitemid 44772111)
27. Brunelli S, Tagliafico E, De Angelis FG, et al. Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ Res 2004;94:1571-1578. (Pubitemid 38856964)
28. Tseng YH, Butte AJ, Kokkotou E, et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol 2005;7:601-611. (Pubitemid 40796983)
29. Nowak K, Kerl K, Fehr D, et al. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res 2006;34:1745-1754.
30. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006;20:1123-1136.
31. Douglas D, Hsu JH, Hung L, et al. BMI-1 promotes Ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res 2008;68:6507-6515.
32. Hayashi Y, Matsuyama K, Takagi K, Sugiura H, Yoshikawa K. Arrest of cell growth by necdin, a nuclear protein expressed in postmitotic neurons. Biochem Biophys Res Commun 1995;213:317-324.
33. Taniura H, Kobayashi M, Yoshikawa K. Functional domains of necdin for protein-protein interaction, nuclear matrix targeting, and cell growth suppression. J Cell Biochem 2005;94:804-815. (Pubitemid 41420277)
34. Nakada Y, Taniura H, Uetsuki T, Yoshikawa K. Characterization and chromosomal mapping of a human Necdin pseudogene. Gene 2000;245:185-191. (Pubitemid 30125378)
35. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004;64:5270-5282. (Pubitemid 39006547)
36. Varma RR, Hector SM, Clark K, Greco WR, Hawthorn L, Pendyala L. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10. Oncol Rep 2005;14:925-932.
37. Kawamata H, Furihata T, Omotehara F, et al. Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray. Cancer Sci 2003;94:699-706. (Pubitemid 37160927)
38. Crawford NP, Walker RC, Lukes L, Officewala JS, Williams RW, Hunter KW. The Diasporin pathway: A tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 2008;25:357-369.
39. van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
40. Davies HD, Leusink GL, McConnell A, et al. Myeloid leukemia in Prader-Willi syndrome. J Pediatr 2003;142:174-178.
41. Gerard M, Hernandez L, Wevrick R, Stewart CL. Disruption of the mouse necdin gene results in early post-natal lethality. Nat Genet 1999;23:199-202. (Pubitemid 29455393)
42. Ren J, Lee S, Pagliardini S, et al. Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J Neurosci 2003;23: 1569-1573. (Pubitemid 36314709)
43. Tsai TF, Armstrong D, Beaudet AL. Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome. Nat Genet 1999;22:15-16. (Pubitemid 29214795)
44. Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, Tainsky MA. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 2003;22:4118-4127. (Pubitemid 36819652)